[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @adamfeuerstein Adam Feuerstein ✡️ Adam Feuerstein ✡️ posts on X about $srpt, $nvo, $rna, $srrk the most. They currently have XXXXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::102094857/interactions)  - X Week XXXXXXX +86% - X Month XXXXXXX +26% - X Months XXXXXXXXX +22% - X Year XXXXXXXXXX +25% ### Mentions: XX [#](/creator/twitter::102094857/posts_active)  - X Week XX -XX% - X Month XXX -XX% - X Months XXX -XXXX% - X Year XXXXX +120% ### Followers: XXXXXXX [#](/creator/twitter::102094857/followers)  - X Week XXXXXXX +0.19% - X Month XXXXXXX +0.71% - X Months XXXXXXX +3.20% - X Year XXXXXXX +4.50% ### CreatorRank: XXXXXXX [#](/creator/twitter::102094857/influencer_rank)  ### Social Influence [#](/creator/twitter::102094857/influence) --- **Social category influence** [stocks](/list/stocks) XXX% [finance](/list/finance) XXXX% [celebrities](/list/celebrities) XXXX% [musicians](/list/musicians) XXXX% [countries](/list/countries) XXXX% [social networks](/list/social-networks) XXXX% [technology brands](/list/technology-brands) XXXX% [currencies](/list/currencies) XXXX% **Social topic influence** [$srpt](/topic/$srpt) #20, [$nvo](/topic/$nvo) #64, [$rna](/topic/$rna) #4, [$srrk](/topic/$srrk) #2, [$akro](/topic/$akro) #10, [$ovid](/topic/$ovid) 0.45%, [$pfe](/topic/$pfe) 0.45%, [$regn](/topic/$regn) #14, [blockbuster](/topic/blockbuster) 0.45%, [collection of](/topic/collection-of) #1557 **Top accounts mentioned or mentioned by** [@elaineywchen](/creator/undefined) [@matthewherper](/creator/undefined) [@bambossie81](/creator/undefined) [@statnews](/creator/undefined) [@jasonmmast](/creator/undefined) [@drewqjoseph](/creator/undefined) [@mbrushstocks](/creator/undefined) [@persimmonti](/creator/undefined) [@samfazeli8](/creator/undefined) [@amaymd](/creator/undefined) [@sanctuarybio](/creator/undefined) [@sanctuary_bio](/creator/undefined) [@biotechch](/creator/undefined) [@yachmod](/creator/undefined) [@helenbranswell](/creator/undefined) [@pharmalot](/creator/undefined) [@a_may_md](/creator/undefined) [@lilienfeld1](/creator/undefined) [@financebully](/creator/undefined) [@yusufhameed](/creator/undefined) **Top assets mentioned** [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Novo-Nordisk (NVO)](/topic/$nvo) [Avidity Biosciences, Inc. Common Stock (RNA)](/topic/$rna) [Scholar Rock Holding Corporation Common Stock (SRRK)](/topic/$srrk) [Akropolis (AKRO)](/topic/$akro) [Pfizer, Inc. (PFE)](/topic/$pfe) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [GSK plc (GSK)](/topic/$gsk) [Acadia Pharmaceuticals Inc. (ACAD)](/topic/$acad) [Merus N.V. Common Shares (MRUS)](/topic/$mrus) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Catalent Inc (CTLT)](/topic/$ctlt) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [Crinetics Pharmaceuticals, Inc. (CRNX)](/topic/$crnx) [Novartis AG (NVS)](/topic/novartis) [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [uniQure N.V. (QURE)](/topic/$qure) [Moderna Inc (MRNA)](/topic/$mrna) [Vera Therapeutics, Inc. Class A Common Stock (VERA)](/topic/$vera) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Soleno Therapeutics, Inc. Common Stock (SLNO)](/topic/$slno) ### Top Social Posts [#](/creator/twitter::102094857/posts) --- Top posts by engagements in the last XX hours "Novo Nordisk $NVO to buy Akero Therapeutics $AKRO picking up promising MASH drug" [X Link](https://x.com/adamfeuerstein/status/1976241589828845765) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-09T11:01Z 121.2K followers, 9434 engagements "Good Monday morning Genmab $GMAB to buy Merus $MRUS in $8B deal via @DrewQJoseph" [X Link](https://x.com/adamfeuerstein/status/1972590225160556736) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-09-29T09:12Z 121.2K followers, 7755 engagements "The limits of FDA flexibility are tested as a controversial Biohaven $BHVN drug decision nears" [X Link](https://x.com/adamfeuerstein/status/1976339766317879427) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-09T17:31Z 121.2K followers, 19.8K engagements "$OVID healthy volunteer data + wall-crossed PIPE raised $175M" [X Link](https://x.com/adamfeuerstein/status/1974069303810080950) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-03T11:09Z 121.2K followers, 14K engagements "$PFE bought a PD1xVEGF antibody from Chinas 3SBio. $1.25B upfront" [X Link](https://x.com/adamfeuerstein/status/1924619787079921967) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-05-20T00:14Z 121.2K followers, 42.2K engagements "A milestone for gene editing. Kyle and Nicole Muldoon mom and dad to Baby KJ share their story at #STATSummit" [X Link](https://x.com/adamfeuerstein/status/1978450873375203386) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-15T13:20Z 121.2K followers, 8643 engagements "@Sanctuary_Bio @somecuriousgirl @DmitryKovalchuk @seedy19tron Agreed and $OVID is a good example of a biotech with very little leverage in this situation. Long road ahead" [X Link](https://x.com/adamfeuerstein/status/1974111199395758137) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-03T13:56Z 121.2K followers, 1433 engagements "$RNA at Cantor today on acquisition chatter. Question But there has been rumors of acquisition interest in your company. What if anything do you want to share about that Answer Yeah. You know look I would say we're now entering into an era another Taylor Swift pun. We're now entering into an era where we're probably going to have a lot of rumors about us and around the interest in Avidity. Well we have three drugs that we're looking to launch in a 12-month period. Two of those drugs we believe are multibillion-dollar indications. So extremely valuable. And I expect here there's going to be" [X Link](https://x.com/adamfeuerstein/status/1963318234301509885) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-09-03T19:08Z 121.2K followers, 16.7K engagements "U.S. drug manufacturing plant did not properly investigate cat hair pests and other problems FDA finds Plant once owned by $CTLT and now owned by Novo Nordisk $NVO is widely used by pharma industry including $REGN and $SRRK via @pharmalot and @elaineywchen" [X Link](https://x.com/adamfeuerstein/status/1958615907678245121) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-08-21T19:43Z 121.2K followers, 36.8K engagements "$SMMT Summit Therapeutics hits possible snag on lung cancer drug seen as a blockbuster Ivonescimab produced weaker results in patients from North America and Europe than those from China" [X Link](https://x.com/adamfeuerstein/status/1964625625177870582) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-09-07T09:43Z 121.2K followers, 49.8K engagements "Duchenne gene therapy stocks today: $SLDB +22% $RGNX +14% $SRPT +1%" [X Link](https://x.com/adamfeuerstein/status/1975955949442727985) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-08T16:06Z 121.2K followers, 16.5K engagements "$SRRK -XX% on today's Catalent mfr plant update. An OAI is not good and could mean a longer delay before approval" [X Link](https://x.com/adamfeuerstein/status/1977713688577527817) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-13T12:31Z 121.2K followers, 23.6K engagements "$RNA - del-zota BLA submission pushed back to Q1 '26 from Q4 '25. "to ensure the FDA receives additional data to support the chemistry manufacturing and controls (CMC) package at time of submission."" [X Link](https://x.com/adamfeuerstein/status/1977726389445857466) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-13T13:21Z 121.2K followers, 10.9K engagements "Sarepta $SRPT to seek approval for gene therapy in rare form of muscular dystrophy The company has said it plans to file for approval in the disease known as limb girdle muscular dystrophy (LGMD) 2E. That would make it the first approved treatment in LGMD a broad collection of highly rare diseases that can deprive patients of the ability to walk and in some case shorten life. But it is likely to face a significant uphill battle. via @Jasonmmast" [X Link](https://x.com/adamfeuerstein/status/1976769839390724271) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-10T22:00Z 121.2K followers, 21.1K engagements "FDA declares Novo Nordisk $NVO (Catalent) plant key to drug manufacturing for some biotechs out of compliance. Impacting $SRRK and $REGN today. via @elaineywchen" [X Link](https://x.com/adamfeuerstein/status/1977745596522914107) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-13T14:37Z 121.2K followers, 17.8K engagements "$AUPH down on this Tidmarsh comment. $SRPT is not" [X Link](https://x.com/adamfeuerstein/status/1972717440204509273) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-09-29T17:37Z 121.2K followers, 16.4K engagements "Skyes $SKYE obesity drug fails in mid-stage study via @elaineywchen" [X Link](https://x.com/adamfeuerstein/status/1975154897676050707) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-06T11:03Z 121.2K followers, 9756 engagements "$SRPT Sarepta suffers a setback as N.Y. panel recommends state Medicaid pause coverage of Duchenne gene therapy Elevidys via @pharmalot" [X Link](https://x.com/adamfeuerstein/status/1975870718568284254) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-08T10:27Z 121.2K followers, 35.4K engagements "Adam why are you not reporting on the $SRPT Elevidys 3-yr data being presented today at WMS Because these very same data were already presented at conferences in May and March. The data ARE NOT NEW" [X Link](https://x.com/adamfeuerstein/status/1975877895311839693) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-08T10:56Z 121.2K followers, 24.4K engagements "FDA brings back $GSK s leucovorin drug that RFK Jr. touted as autism treatment via @DrewQJoseph @_daniel_payne" [X Link](https://x.com/adamfeuerstein/status/1970234942597599735) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-09-22T21:13Z 121.2K followers, 38.4K engagements "What the FDA is doing with $GSK's Wellcovorin (leucovorin) in autism is f--king insane. Sorry but I don't have any other words to describe this action" [X Link](https://x.com/adamfeuerstein/status/1970116084176208377) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-09-22T13:20Z 121.2K followers, 31.1K engagements "$SPRB PIPE buyers locked up until the stock is registered. One month from now The deal was priced at a 5-day average. Buyers were not going to pay the inflated market price. Martin is correct about the makeup of the book. Still will be interesting to see what the PIPE buyers do once their lockup ends. Lot of paper profits now" [X Link](https://x.com/adamfeuerstein/status/1976754298303258688) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-10T20:58Z 121.2K followers, 27.4K engagements "$GSK CEO Walmsley to step down be succeeded by companys commercial lead via @DrewQJoseph" [X Link](https://x.com/adamfeuerstein/status/1972592098147991957) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-09-29T09:19Z 121.2K followers, 6497 engagements "Are real people behind the flood of delusional $SGMO posts or is this just some weird bot campaign" [X Link](https://x.com/adamfeuerstein/status/1975694335711519222) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-07T22:46Z 121.2K followers, 18.9K engagements "Crinetics $CRNX wins FDA approval for acromegaly drug faces competition with Novartis and Ipsen via @JonathanWosen" [X Link](https://x.com/adamfeuerstein/status/1971324752183874035) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-09-25T21:23Z 121.2K followers, 21.8K engagements ".the firings on Friday affected the CDC's Office of Safety Security and Asset Management which is responsible for agency security. . only weeks after a gunman fired XXX bullets at the agencys Atlanta headquarters killing a police officer and shaking staff members facing unprecedented policy changes as well as fears about the politicization of public health" [X Link](https://x.com/adamfeuerstein/status/1977084458990805343) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-11T18:50Z 121.2K followers, 9308 engagements "@Sanctuary_Bio @A_May_MD @BlaseBio ARK Funds have been buying $NTLA recently for instance" [X Link](https://x.com/adamfeuerstein/status/1975674064145383815) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-07T21:26Z 121.2K followers, 4799 engagements "I am finalist for a @LoebAwards in the commentary category. Also named Loeb finalists from @statnews: -- Lev Facher for his "War on Recovery" series in the explanatory category. -- The UnitedHealth Group "Colossus" series by @caseyross @bobjherman @TaraBannow and @LizzyLaw_ in the beat reporting category" [X Link](https://x.com/adamfeuerstein/status/1961139452358599040) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-08-28T18:50Z 121.2K followers, 11.3K engagements "How North Carolina built manufacturing boomtowns for biotech As the industry sags elsewhere in the country the state has become a go-to destination Great on-the-ground reporting from @ADeAngelis_bio" [X Link](https://x.com/adamfeuerstein/status/1978441438502240745) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-15T12:42Z 121.2K followers, 7492 engagements "Update: Some of the firings are being rescinded. Its a massacre: CDC battered by government shutdown firings via @statnews" [X Link](https://x.com/adamfeuerstein/status/1977146747249213468) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-11T22:58Z 121.2K followers, 22.7K engagements "@A_May_MD @BlaseBio I would say Cathie Wood staying out of $QURE would be a bullish sign" [X Link](https://x.com/adamfeuerstein/status/1975664106133717101) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-07T20:46Z 121.2K followers, 4857 engagements "$ACAD halted. ACP-101 data" [X Link](https://x.com/adamfeuerstein/status/1970805127213723748) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-09-24T10:58Z 121.2K followers, 5691 engagements "The NY State vote on $SRPT Elevidys was last Friday. Technically last week but it took my colleague a day plus to get clarity on what the decision meant and its implications. Thats called reporting. It takes time. More than a tweet. The suggestion that we delayed a story for any reason is false and absurd" [X Link](https://x.com/adamfeuerstein/status/1976076611423285709) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-09T00:05Z 121.2K followers, 1046 engagements "The gov't shutdown means FDA is not accepting drug-approval applications. I did quick scan of potentially affected drug makers defined by me as companies that have guided to filings by EOY. $VRDN $RNA $MRNA $COGT $VERA Any others add in replies" [X Link](https://x.com/adamfeuerstein/status/1973376736193601637) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-01T13:17Z 121.2K followers, 21.2K engagements "It's getting testy per Bloomberg. BridgeBio $BBIO Says Pfizer $PFE Alnylam $ALNY Arent Playing Fair in Blockbuster Race" [X Link](https://x.com/adamfeuerstein/status/1966216814473740529) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-09-11T19:06Z 121.2K followers, 21.9K engagements "Here's the story: Monopar $MNPR resurrects a shelved Wilson disease drug. Spotting a possible math problem helped" [X Link](https://x.com/adamfeuerstein/status/1976248581775569006) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-09T11:29Z 121.2K followers, 6510 engagements "Read the story here: As Sarepta Therapeutics $SRPT fights for Duchenne therapy a group of patients gets left behind Families with limb-girdle muscular dystrophy hoped for gene therapy but overnight its gone" [X Link](https://x.com/adamfeuerstein/status/1958490724975915429) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-08-21T11:25Z 121.2K followers, 8199 engagements "This week's Biotech Scorecard newsletter: Monopar $MNPR and the resurrection of a shelved drug for Wilson disease. It's a crazy story. AstraZeneca the drugs former owner terminated clinical development in 2023 due to an inadvertent error made in a clinical trial. Monopar acquired the drug last year and then discovered the mistake made in a formula used to analyze copper elimination from the body. If approved possibly in the latter half of 2026 the drug called ALXN1840 would be the first novel treatment for Wilson disease in XX years. Monopar plans to submit for U.S. approval early next year" [X Link](https://x.com/adamfeuerstein/status/1976248580294819856) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-09T11:29Z 121.2K followers, 16.8K engagements "Jaw-dropping incompetence: An HHS official speaking on background said that some people may have mistakenly received reduction-in-force notices because of coding errors in their job classifications. The people who should be brought back the official said include those who produce the Morbidity and Mortality Weekly Report publication people working on the measles outbreak people working on the Ebola outbreak in the Democratic Republic of Congo and people in the Global Health Center and in the Epidemic Intelligence Service" [X Link](https://x.com/adamfeuerstein/status/1977174288491839785) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-12T00:47Z 121.2K followers, 47.8K engagements "From Jason's $SRPT story: Even as Sarepta fought to keep its Duchenne treatment Elevidys on the market despite the deaths of two teenagers it pulled out of a nearly decade-long commitment to develop gene therapies for limb-girdle muscular dystrophy a lesser known collection of over XX ultra-rare and debilitating muscle disorders. The news devastated patients and families who for years watched their programs inch along while Sarepta devoted most of its resources to Duchenne the most well known and universally fatal form of muscular dystrophy. The company had only just started a clinical trial" [X Link](https://x.com/adamfeuerstein/status/1958490723646345504) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-08-21T11:25Z 121.2K followers, 9055 engagements "$NVO is acquiring $AKRO $XX per share plus a $X VCR" [X Link](https://x.com/adamfeuerstein/status/1976227896130928873) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-10-09T10:07Z 121.2K followers, 20.1K engagements "$ACAD ACAP-101 study in Prader-Willi failed to improve hyperphagia behavior. $SLNO" [X Link](https://x.com/adamfeuerstein/status/1970806448734290213) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-09-24T11:04Z 121.2K followers, 7794 engagements "Another twist. FDA permits use of Sarepta Therapeutics $SRPT Duchenne therapy in younger patients after short-lived halt" [X Link](https://x.com/adamfeuerstein/status/1949937792517067181) [@adamfeuerstein](/creator/x/adamfeuerstein) 2025-07-28T20:59Z 121.2K followers, 25.2K engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Adam Feuerstein ✡️ posts on X about $srpt, $nvo, $rna, $srrk the most. They currently have XXXXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.
Social category influence stocks XXX% finance XXXX% celebrities XXXX% musicians XXXX% countries XXXX% social networks XXXX% technology brands XXXX% currencies XXXX%
Social topic influence $srpt #20, $nvo #64, $rna #4, $srrk #2, $akro #10, $ovid 0.45%, $pfe 0.45%, $regn #14, blockbuster 0.45%, collection of #1557
Top accounts mentioned or mentioned by @elaineywchen @matthewherper @bambossie81 @statnews @jasonmmast @drewqjoseph @mbrushstocks @persimmonti @samfazeli8 @amaymd @sanctuarybio @sanctuary_bio @biotechch @yachmod @helenbranswell @pharmalot @a_may_md @lilienfeld1 @financebully @yusufhameed
Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Novo-Nordisk (NVO) Avidity Biosciences, Inc. Common Stock (RNA) Scholar Rock Holding Corporation Common Stock (SRRK) Akropolis (AKRO) Pfizer, Inc. (PFE) Regeneron Pharmaceuticals Inc (REGN) GSK plc (GSK) Acadia Pharmaceuticals Inc. (ACAD) Merus N.V. Common Shares (MRUS) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Catalent Inc (CTLT) Summit Therapeutics Inc. Common Stock (SMMT) Crinetics Pharmaceuticals, Inc. (CRNX) Novartis AG (NVS) Intellia Therapeutics, Inc (NTLA) uniQure N.V. (QURE) Moderna Inc (MRNA) Vera Therapeutics, Inc. Class A Common Stock (VERA) BridgeBio Pharma, Inc. Common Stock (BBIO) Alnylam Pharmaceuticals, Inc. (ALNY) Soleno Therapeutics, Inc. Common Stock (SLNO)
Top posts by engagements in the last XX hours
"Novo Nordisk $NVO to buy Akero Therapeutics $AKRO picking up promising MASH drug"
X Link @adamfeuerstein 2025-10-09T11:01Z 121.2K followers, 9434 engagements
"Good Monday morning Genmab $GMAB to buy Merus $MRUS in $8B deal via @DrewQJoseph"
X Link @adamfeuerstein 2025-09-29T09:12Z 121.2K followers, 7755 engagements
"The limits of FDA flexibility are tested as a controversial Biohaven $BHVN drug decision nears"
X Link @adamfeuerstein 2025-10-09T17:31Z 121.2K followers, 19.8K engagements
"$OVID healthy volunteer data + wall-crossed PIPE raised $175M"
X Link @adamfeuerstein 2025-10-03T11:09Z 121.2K followers, 14K engagements
"$PFE bought a PD1xVEGF antibody from Chinas 3SBio. $1.25B upfront"
X Link @adamfeuerstein 2025-05-20T00:14Z 121.2K followers, 42.2K engagements
"A milestone for gene editing. Kyle and Nicole Muldoon mom and dad to Baby KJ share their story at #STATSummit"
X Link @adamfeuerstein 2025-10-15T13:20Z 121.2K followers, 8643 engagements
"@Sanctuary_Bio @somecuriousgirl @DmitryKovalchuk @seedy19tron Agreed and $OVID is a good example of a biotech with very little leverage in this situation. Long road ahead"
X Link @adamfeuerstein 2025-10-03T13:56Z 121.2K followers, 1433 engagements
"$RNA at Cantor today on acquisition chatter. Question But there has been rumors of acquisition interest in your company. What if anything do you want to share about that Answer Yeah. You know look I would say we're now entering into an era another Taylor Swift pun. We're now entering into an era where we're probably going to have a lot of rumors about us and around the interest in Avidity. Well we have three drugs that we're looking to launch in a 12-month period. Two of those drugs we believe are multibillion-dollar indications. So extremely valuable. And I expect here there's going to be"
X Link @adamfeuerstein 2025-09-03T19:08Z 121.2K followers, 16.7K engagements
"U.S. drug manufacturing plant did not properly investigate cat hair pests and other problems FDA finds Plant once owned by $CTLT and now owned by Novo Nordisk $NVO is widely used by pharma industry including $REGN and $SRRK via @pharmalot and @elaineywchen"
X Link @adamfeuerstein 2025-08-21T19:43Z 121.2K followers, 36.8K engagements
"$SMMT Summit Therapeutics hits possible snag on lung cancer drug seen as a blockbuster Ivonescimab produced weaker results in patients from North America and Europe than those from China"
X Link @adamfeuerstein 2025-09-07T09:43Z 121.2K followers, 49.8K engagements
"Duchenne gene therapy stocks today: $SLDB +22% $RGNX +14% $SRPT +1%"
X Link @adamfeuerstein 2025-10-08T16:06Z 121.2K followers, 16.5K engagements
"$SRRK -XX% on today's Catalent mfr plant update. An OAI is not good and could mean a longer delay before approval"
X Link @adamfeuerstein 2025-10-13T12:31Z 121.2K followers, 23.6K engagements
"$RNA - del-zota BLA submission pushed back to Q1 '26 from Q4 '25. "to ensure the FDA receives additional data to support the chemistry manufacturing and controls (CMC) package at time of submission.""
X Link @adamfeuerstein 2025-10-13T13:21Z 121.2K followers, 10.9K engagements
"Sarepta $SRPT to seek approval for gene therapy in rare form of muscular dystrophy The company has said it plans to file for approval in the disease known as limb girdle muscular dystrophy (LGMD) 2E. That would make it the first approved treatment in LGMD a broad collection of highly rare diseases that can deprive patients of the ability to walk and in some case shorten life. But it is likely to face a significant uphill battle. via @Jasonmmast"
X Link @adamfeuerstein 2025-10-10T22:00Z 121.2K followers, 21.1K engagements
"FDA declares Novo Nordisk $NVO (Catalent) plant key to drug manufacturing for some biotechs out of compliance. Impacting $SRRK and $REGN today. via @elaineywchen"
X Link @adamfeuerstein 2025-10-13T14:37Z 121.2K followers, 17.8K engagements
"$AUPH down on this Tidmarsh comment. $SRPT is not"
X Link @adamfeuerstein 2025-09-29T17:37Z 121.2K followers, 16.4K engagements
"Skyes $SKYE obesity drug fails in mid-stage study via @elaineywchen"
X Link @adamfeuerstein 2025-10-06T11:03Z 121.2K followers, 9756 engagements
"$SRPT Sarepta suffers a setback as N.Y. panel recommends state Medicaid pause coverage of Duchenne gene therapy Elevidys via @pharmalot"
X Link @adamfeuerstein 2025-10-08T10:27Z 121.2K followers, 35.4K engagements
"Adam why are you not reporting on the $SRPT Elevidys 3-yr data being presented today at WMS Because these very same data were already presented at conferences in May and March. The data ARE NOT NEW"
X Link @adamfeuerstein 2025-10-08T10:56Z 121.2K followers, 24.4K engagements
"FDA brings back $GSK s leucovorin drug that RFK Jr. touted as autism treatment via @DrewQJoseph @_daniel_payne"
X Link @adamfeuerstein 2025-09-22T21:13Z 121.2K followers, 38.4K engagements
"What the FDA is doing with $GSK's Wellcovorin (leucovorin) in autism is f--king insane. Sorry but I don't have any other words to describe this action"
X Link @adamfeuerstein 2025-09-22T13:20Z 121.2K followers, 31.1K engagements
"$SPRB PIPE buyers locked up until the stock is registered. One month from now The deal was priced at a 5-day average. Buyers were not going to pay the inflated market price. Martin is correct about the makeup of the book. Still will be interesting to see what the PIPE buyers do once their lockup ends. Lot of paper profits now"
X Link @adamfeuerstein 2025-10-10T20:58Z 121.2K followers, 27.4K engagements
"$GSK CEO Walmsley to step down be succeeded by companys commercial lead via @DrewQJoseph"
X Link @adamfeuerstein 2025-09-29T09:19Z 121.2K followers, 6497 engagements
"Are real people behind the flood of delusional $SGMO posts or is this just some weird bot campaign"
X Link @adamfeuerstein 2025-10-07T22:46Z 121.2K followers, 18.9K engagements
"Crinetics $CRNX wins FDA approval for acromegaly drug faces competition with Novartis and Ipsen via @JonathanWosen"
X Link @adamfeuerstein 2025-09-25T21:23Z 121.2K followers, 21.8K engagements
".the firings on Friday affected the CDC's Office of Safety Security and Asset Management which is responsible for agency security. . only weeks after a gunman fired XXX bullets at the agencys Atlanta headquarters killing a police officer and shaking staff members facing unprecedented policy changes as well as fears about the politicization of public health"
X Link @adamfeuerstein 2025-10-11T18:50Z 121.2K followers, 9308 engagements
"@Sanctuary_Bio @A_May_MD @BlaseBio ARK Funds have been buying $NTLA recently for instance"
X Link @adamfeuerstein 2025-10-07T21:26Z 121.2K followers, 4799 engagements
"I am finalist for a @LoebAwards in the commentary category. Also named Loeb finalists from @statnews: -- Lev Facher for his "War on Recovery" series in the explanatory category. -- The UnitedHealth Group "Colossus" series by @caseyross @bobjherman @TaraBannow and @LizzyLaw_ in the beat reporting category"
X Link @adamfeuerstein 2025-08-28T18:50Z 121.2K followers, 11.3K engagements
"How North Carolina built manufacturing boomtowns for biotech As the industry sags elsewhere in the country the state has become a go-to destination Great on-the-ground reporting from @ADeAngelis_bio"
X Link @adamfeuerstein 2025-10-15T12:42Z 121.2K followers, 7492 engagements
"Update: Some of the firings are being rescinded. Its a massacre: CDC battered by government shutdown firings via @statnews"
X Link @adamfeuerstein 2025-10-11T22:58Z 121.2K followers, 22.7K engagements
"@A_May_MD @BlaseBio I would say Cathie Wood staying out of $QURE would be a bullish sign"
X Link @adamfeuerstein 2025-10-07T20:46Z 121.2K followers, 4857 engagements
"$ACAD halted. ACP-101 data"
X Link @adamfeuerstein 2025-09-24T10:58Z 121.2K followers, 5691 engagements
"The NY State vote on $SRPT Elevidys was last Friday. Technically last week but it took my colleague a day plus to get clarity on what the decision meant and its implications. Thats called reporting. It takes time. More than a tweet. The suggestion that we delayed a story for any reason is false and absurd"
X Link @adamfeuerstein 2025-10-09T00:05Z 121.2K followers, 1046 engagements
"The gov't shutdown means FDA is not accepting drug-approval applications. I did quick scan of potentially affected drug makers defined by me as companies that have guided to filings by EOY. $VRDN $RNA $MRNA $COGT $VERA Any others add in replies"
X Link @adamfeuerstein 2025-10-01T13:17Z 121.2K followers, 21.2K engagements
"It's getting testy per Bloomberg. BridgeBio $BBIO Says Pfizer $PFE Alnylam $ALNY Arent Playing Fair in Blockbuster Race"
X Link @adamfeuerstein 2025-09-11T19:06Z 121.2K followers, 21.9K engagements
"Here's the story: Monopar $MNPR resurrects a shelved Wilson disease drug. Spotting a possible math problem helped"
X Link @adamfeuerstein 2025-10-09T11:29Z 121.2K followers, 6510 engagements
"Read the story here: As Sarepta Therapeutics $SRPT fights for Duchenne therapy a group of patients gets left behind Families with limb-girdle muscular dystrophy hoped for gene therapy but overnight its gone"
X Link @adamfeuerstein 2025-08-21T11:25Z 121.2K followers, 8199 engagements
"This week's Biotech Scorecard newsletter: Monopar $MNPR and the resurrection of a shelved drug for Wilson disease. It's a crazy story. AstraZeneca the drugs former owner terminated clinical development in 2023 due to an inadvertent error made in a clinical trial. Monopar acquired the drug last year and then discovered the mistake made in a formula used to analyze copper elimination from the body. If approved possibly in the latter half of 2026 the drug called ALXN1840 would be the first novel treatment for Wilson disease in XX years. Monopar plans to submit for U.S. approval early next year"
X Link @adamfeuerstein 2025-10-09T11:29Z 121.2K followers, 16.8K engagements
"Jaw-dropping incompetence: An HHS official speaking on background said that some people may have mistakenly received reduction-in-force notices because of coding errors in their job classifications. The people who should be brought back the official said include those who produce the Morbidity and Mortality Weekly Report publication people working on the measles outbreak people working on the Ebola outbreak in the Democratic Republic of Congo and people in the Global Health Center and in the Epidemic Intelligence Service"
X Link @adamfeuerstein 2025-10-12T00:47Z 121.2K followers, 47.8K engagements
"From Jason's $SRPT story: Even as Sarepta fought to keep its Duchenne treatment Elevidys on the market despite the deaths of two teenagers it pulled out of a nearly decade-long commitment to develop gene therapies for limb-girdle muscular dystrophy a lesser known collection of over XX ultra-rare and debilitating muscle disorders. The news devastated patients and families who for years watched their programs inch along while Sarepta devoted most of its resources to Duchenne the most well known and universally fatal form of muscular dystrophy. The company had only just started a clinical trial"
X Link @adamfeuerstein 2025-08-21T11:25Z 121.2K followers, 9055 engagements
"$NVO is acquiring $AKRO $XX per share plus a $X VCR"
X Link @adamfeuerstein 2025-10-09T10:07Z 121.2K followers, 20.1K engagements
"$ACAD ACAP-101 study in Prader-Willi failed to improve hyperphagia behavior. $SLNO"
X Link @adamfeuerstein 2025-09-24T11:04Z 121.2K followers, 7794 engagements
"Another twist. FDA permits use of Sarepta Therapeutics $SRPT Duchenne therapy in younger patients after short-lived halt"
X Link @adamfeuerstein 2025-07-28T20:59Z 121.2K followers, 25.2K engagements
/creator/twitter::adamfeuerstein